Vaginal gel cuts HIV infections as much as 54 percent, trial shows
Links shared publicly online about this topic.
- 1,010total visits
Vaginal gel cuts HIV infections as much as 54 percent, trial shows
July 19 (Bloomberg) -- A vaginal gel containing Gilead Sciences Inc.'s AIDS drug Viread cut HIV infections by as much as 54 percent in a trial in South Africa, the first time such a product has protected users after six previous gels failed.
View full resource at washingtonpost.com
Tags: Infection, HIV, AIDS, HIV Medication, STD, Drug, Viread, Gilead Sciences
Most Recently Shared on July 19, 2010 at 6:33 pm By:
Vaginal gel cuts HIV infections as much as 54 percent, trial shows http://ow.ly/18cslJ
Observations: Vaginal gel shows effectiveness in preventing HIV in women
scientificamerican.com — “A vaginal microbicide can cut HIV infection rates by 39 percent in women, researchers announced Monday. And female study participants who inserted the gel as directed reduced their chances of contracting HIV by more than half (54 percent). The news is a” View full resource at scientificamerican.com
Most Recently Shared on July 19, 2010 at 10:10 pm By:
How did this trial get past ethics!?? Vaginal gel shows effectiveness in preventing HIV in women http://bit.ly/bvSjHU
Advertisement
